Unibest

Pharmaceutical intermediates

Imeglimin hydrochloride Intermediates

1 pharmaceutical intermediate for Imeglimin hydrochloride. Indication: Type 2 diabetes mellitus.

提交项目All intermediates

About Imeglimin hydrochloride

Originator
Merck Kgaa
Indication
Type 2 diabetes mellitus
Approved Date
06/23/2021

Available intermediates

1 intermediate currently listed for Imeglimin hydrochloride. Request specifications, documentation or a quotation for any item below.

Imeglimin hydrochloride intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
N-VINYLFORMAMIDE13162-05-5//

Other programs under I

Ibrutinib/ Zanubrutinib IguratimodImatinibIndacaterol MaleateInfigratinibIpatacopan HydrochlorideIpragliflozinIrinotecan

Building toward Imeglimin hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →